Thousands of patients at risk as Parkinson’s, epilepsy and blood clot drugs are recalled – The Sun

0
16
Thousands of patients at risk as Parkinson’s, epilepsy and blood clot drugs are recalled – The Sun



THOUSANDS of Parkinson’s, epilepsy and heart patients are at risk over fears their drugs could be ineffective.
The Medicines and Healthcare Regulatory Agency has recalled three types of drugs – and is urging patients to check if they are affected.
1 The medicines regulator MHRA has recalled batches of drugs imported the UK by B & S Healthcare, over fears they may be ineffective
They are Neupro for Parkinson’s disease, Vimpat for epilepsy and Clexane, which is used to treat blood clots.
The MHRA warned the drugs, imported to the UK by B&S Healthcare, may not have been stored correctly and while it’s unlikely, as a result they could be less effective in treating the conditions.Continue taking medication
Dr Samantha Atkinson, from the MHRA, urged patients to continue taking their drugs, but book an appointment with their GP to get a new prescription.
Once patients have their new prescription, they should take the affected drugs back to the pharmacy.
In addition, six other medications are being recalled at pharmacy level.
They are:

chronic obstructive pulmonary disease – Spiriva Inhalation Powder, Incruse Inhaler, Seebri Breezhaler
psoriasis – Dovobet Gel
high cholesterol – Provisacor and Crestor
For the full list of the affected batches visit the MHRA website here

Again patients should continue to take the medicine, but don’t need to arrange a new prescription. If patients have concerns they should speak to a pharmacist or their GP.
B & S Healthcare is carrying out a recall and MHRA has alerted pharmacies – calling on them to return the affect medicine to the supplier.
Risks are low
The affected drugs are believed to be legitimate, but were taken out of the regulated supply chain during distribution and were later re-introduced.
It means inspectors can’t be certain the drugs were stored correctly.
ARE YOUR DRUGS AFFECTED?THE drugs recalled by MHRA are:

Neupro for Parkinson’s disease
Vimpat for epilepsy
Clexane, which is used to treat blood clots

If you take these drugs continue with your doses but book an appointment to see your GP for a new prescription.
The other drugs being recalled at pharmacy level are:

Spiriva Inhalation Powder, Incruse Inhaler, Seebri Breezhaler – for chronic obstructive pulmonary disease
Dovobet Gel for psoriasis
Provisacor and Crestor for high cholesterol

If you take these drugs, carry on and raise any concerns with your GP or pharmacist.
Patients can check their medicines by looking for the affected batch numbers on the MHRA website here.
The recall relates to B & S Healthcare labelled products.
The drugs are all in the original Italian packaging with the UK manufacturer’s B & S Healthcare label on the front.

As a result there is a possibility the medication may not be effective.
MHRA said there is no evidence the drugs were tampered with.
A spokesman said: “This means that the risk of these medicines not being fully effective is greatly reduced or negligible.
“Therefore patients should continue taking their medicine.”
SLAPPY ENDING Baldness cure for millions close after scientists grow ‘unlimited’ hair BIRTH NIGHTMARE Mum wanting more kids woke up from C-section to find she’d been sterilised LET DOWN Mum’s anger as daughter killed herself after NHS told her to keep ‘mood diary’ SNACK FLAK Feeding kids so-called ‘healthy snacks’ is ‘no better than giving them sweets’ cancer test row Men who identify as women are invited for cervical smear without a cervix HIGH ALERT Norovirus outbreak closes hospital wards as docs urge people to stay away ExclusiveBUG INVASION ‘Plague of mosquitoes’ will invade UK next WEEK as Saharan ‘heat bubble’ hits WEATHER BOMB Millions at risk of deadly asthma as Saharan ‘heat bubble’ hits deadly mistakes NHS 111 ‘missed FIVE chances’ to save boy, 6, who died holding dad’s hand
Dr Atkinson said the recall is part of an ongoing investigation.
“Making sure the medicines people and their families take are acceptably safe and effective is the primary role of the MHRA and is our highest priority,” she said.
“When we are made aware of potential risks to the security of the supply chain, the MHRA takes action to protect the public.
“We continuously strive to ensure the UK’s regulated supply chain remains one of the safest in the world.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here